The Safety and Efficacy of Etanercept on Cardiac Functions and Lipid Profile in Patients With Active Rheumatoid Arthritis

ŞENEL S., Cobankara V., Taskoylu O., Karasu U., KARAPINAR H., ERDİŞ E., ...Daha Fazla

JOURNAL OF INVESTIGATIVE MEDICINE, cilt.60, sa.1, ss.62-65, 2012 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 60 Sayı: 1
  • Basım Tarihi: 2012
  • Doi Numarası: 10.2310/jim.0b013e31823a00f4
  • Dergi Adı: JOURNAL OF INVESTIGATIVE MEDICINE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.62-65
  • Sivas Cumhuriyet Üniversitesi Adresli: Evet

Özet

Objectives: Patients with rheumatoid arthritis (RA) are known to be at increased cardiovascular risk. Etanercept is a tumor necrosis factor alpha (TNF-alpha) blocking agent that has been successfully used in the treatment of RA. We sought to assess the effects of etanercept on cardiac functions and lipid profile in RA patients without overt cardiac disease.